Biohaven’s pipeline drug BHV-7000 has failed to meet the primary endpoint in a pivotal Phase II/III bipolar trial.

Amgen and AstraZeneca have reported outcomes from the WAYPOINT trial of Tezspire for treating chronic rhinosinusitis with ...

NeOnc claims that its novel intranasal delivery platform will be able to bypass the blood-brain barrier and better target ...

The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

The CoTikiS trial’s 10-week results from the 50-week ulcerative colitis trial saw as an endoscopic improvement rate of 32% in ...

The Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...

Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...

Novadip's bone graft material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the Phase IIb RELIEVE UCCD trial of duvakitug.